Back

Medscape, LLC

  • Castration
  • Prostatic Neoplasms
  • Radiopharmaceuticals

Building Care Plans With Radiopharmaceuticals for Patients With mCRPC

The goal of this activity is for learners to be better able to manage metastatic castration-resistant prostate cancer (mCRPC) with new approaches to radiopharmaceutical care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Faculty 1

All faculty
  • Neal Shore, DR

    Director, START Carolinas/Carolina Urologic Research Center, AUC Urology Specialists

    Urology

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Mar 17, 2026
  • Last day to claim credit
    Mar 18, 2027 5 months left